Neuren Pharmaceuticals Limited

Patrick Davies / Jon Pilcher

Chair / CEO

Investor Dashboard

Subscribe to receive announcements and updates live from Neuren.

Scientific Publications and Presentations

Our Science

SCIENCE

Other programs

Compassionate Use

Hypoxic-ischemic encephalopathy

Pitt Hopkins Syndrome

Phelan-McDermid Syndrome

PIPELINE

DAYBUE®

PRODUCTS

Corporate Directory

Executive Management

Team

Company Values

ABOUT US

Corporate Governance

Home

Updates

Analyst Coverage

Investor Presentations

Annual and Interim Reports

ASX Announcements

Share Price Information

Plus Jakarta Sans

Neuren Pharmaceuticals

We are grateful to our shareholders and the whole Neuren team for their ongoing dedication to what we all believe is such a meaningful mission. Delivering the impact on patients and their families that we are striving for should ultimately result in highly positive outcomes for all stakeholders.

MUFG Corporate Markets
Level 13, Tower 4
727 Collins Street
Melbourne VIC 3000

8:30am to 7:30pm - Monday to Friday (excluding Public Holidays)